Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
« Previous Article | Table of Contents | Next Article »
Arteriosclerosis, Thrombosis, and Vascular Biology. 1989;9:154-158

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hollmann, J.
Right arrow Articles by Buddecke, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hollmann, J.
Right arrow Articles by Buddecke, E.

Arteriosclerosis, Vol 9, 154-158, Copyright © 1989 by American Heart Association

ARTICLES

Relationship of sulfated glycosaminoglycans and cholesterol content in normal and arteriosclerotic human aorta

J Hollmann, A Schmidt, DB von Bassewitz and E Buddecke
Institute of Physiological Chemistry, University of Munster, Federal Republic of Germany.

Sulfated glycosaminoglycans were extracted from arteriosclerotic and adjacent nonarteriosclerotic areas of human aortas from persons ages 28 to 83 years; the glycosaminoglycans were compared with the cholesterol and triglyceride content of the tissues. Sulfated glycosaminoglycans were isolated after proteolytic digestion of defatted arterial tissue and were quantified after reductive labeling with NaB3H4. The amount of glycosaminoglycans in the aorta increased with the age of the person and the cholesterol content (degree of arteriosclerosis) of the aorta. The proportion of chondroitin sulfate/dermatan sulfate increased significantly with age and cholesterol content, whereas the corresponding amounts of heparan sulfate decreased.


This article has been cited by other articles:


Home page
 Circ. Res.Home page
K. Tran-Lundmark, P.-K. Tran, G. Paulsson-Berne, V. Friden, R. Soininen, K. Tryggvason, T. N. Wight, M. G. Kinsella, J. Boren, and U. Hedin
Heparan Sulfate in Perlecan Promotes Mouse Atherosclerosis: Roles in Lipid Permeability, Lipid Retention, and Smooth Muscle Cell Proliferation
Circ. Res., July 3, 2008; 103(1): 43 - 52.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
F. Huang, J. C. Thompson, P. G. Wilson, H. H. Aung, J. C. Rutledge, and L. R. Tannock
Angiotensin II increases vascular proteoglycan content preceding and contributing to atherosclerosis development
J. Lipid Res., March 1, 2008; 49(3): 521 - 530.
[Abstract] [Full Text] [PDF]

Home page
 British Journal of Diabetes & Vascular DiseaseHome page
J. Xu, E. T Lee, L. G Best, M. Begum, W. C Knowler, R. R Fabsitz, and B. V Howard
Association of albuminuria with all-cause and cardiovascular disease mortality in diabetes: the Strong Heart Study
The British Journal of Diabetes & Vascular Disease, November 1, 2005; 5(6): 334 - 340.
[Abstract] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. C. Rodrigo, D. S. Martin, and K. M. Eyster
Estrogen decreases biglycan mRNA expression in resistance blood vessels
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2003; 285(4): R754 - R761.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
J. E. Liu, D. C. Robbins, V. Palmieri, J. N. Bella, M. J. Roman, R. Fabsitz, B. V. Howard, T. K. Welty, E. T. Lee, and R. B. Devereux
Association of albuminuria with systolic and diastolic left ventricular dysfunction in type 2 diabetes: The Strong Heart Study
J. Am. Coll. Cardiol., June 4, 2003; 41(11): 2022 - 2028.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
K. J. Williams
Editorial: The Mystery--and Importance--of Diabetic Atherosclerotic Vascular Disease
J. Clin. Endocrinol. Metab., January 1, 2002; 87(1): 33 - 34.
[Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. Paka, Y. Kako, J. C. Obunike, and S. Pillarisetti
Apolipoprotein E Containing High Density Lipoprotein Stimulates Endothelial Production of Heparan Sulfate Rich in Biologically Active Heparin-like Domains. A POTENTIAL MECHANISM FOR THE ANTI-ATHEROGENIC ACTIONS OF VASCULAR APOLIPOPROTEIN E
J. Biol. Chem., February 19, 1999; 274(8): 4816 - 4823.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
P. Sartipy, G. Bondjers, and E. Hurt-Camejo
Phospholipase A2 Type II Binds to Extracellular Matrix Biglycan : Modulation of Its Activity on LDL by Colocalization in Glycosaminoglycan Matrixes
Arterioscler Thromb Vasc Biol, December 1, 1998; 18(12): 1934 - 1941.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
E. C. Tozer and T. E. Carew
Residence Time of Low-Density Lipoprotein in the Normal and Atherosclerotic Rabbit Aorta
Circ. Res., February 1, 1997; 80(2): 208 - 218.
[Abstract] [Full Text]

Home page
 CLIN APPL THROMB HEMOSTHome page
H. Engelberg
State-of the-Art Review : Endogenous Heparin Activity Deficiency and Atherosclerosis
Clinical and Applied Thrombosis/Hemostasis, April 1, 1996; 2(2): 83 - 93.
[PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
J. S. Jensen
Renal and Systemic Transvascular Albumin Leakage in Severe Atherosclerosis
Arterioscler Thromb Vasc Biol, September 1, 1995; 15(9): 1324 - 1329.
[Abstract] [Full Text]

Home page
 CirculationHome page
J. Kuusisto, L. Mykkanen, K. Pyorala, and M. Laakso
Hyperinsulinemic Microalbuminuria : A New Risk Indicator for Coronary Heart Disease
Circulation, February 1, 1995; 91(3): 831 - 837.
[Abstract] [Full Text]


ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search
Copyright © 1989 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited.